SIVB - SVBファイナンシャル・グル―プ (SVB Financial Group)

SIVBのニュース

   Qiming Leads $29M New Round In Chinese AI Medical Firm Shukun Technology  2020/08/31 03:16:06 China Money Network
Qiming Venture Partners has recently led a RMB200 million (US$29.18 million) new round in Chinese AI medical company Shukun Technology. ThunderSoft, Everest Capital and SPD Silicon Valley Bank also participated in the new round. The latest round is just after the completion of a RMB200 million series B1 financing round in June this year, led […] Qiming Leads $29M New Round In Chinese AI Medical Firm Shukun Technology comes from China Money Network : Primary Data for China's Primary Markets! All Rights Reserved.
   Medical Fish Skin Company Kerecis Secures USD 21 Million Financing  2020/08/27 10:00:00 Business Wire
ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #financing--Kerecis Limited, a regenerative-medicine biologics company, has secured $21 million in new financing. Silicon Valley Bank is providing a revolving line of credit of up to $15 million to meet the company’s near-term working-capital needs. Also, the company’s leading investors and other lenders have provided the company with $6 million in loans that largely consist of convertible notes. The funding will be used to support the company’s expansi
   Dundalk’s Diaceutics raises €4.45m from Silicon Valley Bank  2020/08/26 07:48:51 SiliconRepublic
The funding will be used over the next three years to support Diaceutics as it continues its global expansion and accelerates product development.
   Everstone, Goldman Sachs buy into US based Infostretch  2020/08/18 13:33:05 Economic Times India
Infostretch’s customer list includes BMW, GlobeOne, Knipper, L'Oreal, Marriott, Roche, Silicon Valley Bank, Starwood, T-Mobile and Vodafone.
   Joe Biden officially accepts the Democratic nomination this week. RBC says buy these 47 stocks spanning every industry that are poised to crush the market if he wins in a wave election.  2020/08/16 12:10:00 Business Insider
RBC's stock analysts are decidedly bearish on the prospect of a Joe Biden presidency, but they're still naming the most promising stocks in every industry represented on the S&P 500. Lori Calvasina, the head of US equity strategy, says those analysts think Biden and a fully Democratic government would be good news for utilities and some healthcare sectors, but not many others. Their ideas could help investors target the companies with the most to gain and limit their downside if the prospect of higher taxes weighs on markets. Click here to sign up for our weekly newsletter Investing Insider . Visit Business Insider's homepage for more stories . One of Joe Biden's favorite campaign trail quotes is "Our best days still lie ahead." RBC's line on Biden is more like "Try to make the best of it." According to Lori Calvasina, the head of US equity strategy, most of her firm's analysts are bearish on what Biden's agenda would mean for the industries they cover. The former vice president is scheduled to accept the Democratic nomination on Thursday. "Our analysts see Biden as a bullish outcome for Utilities … and a bearish outcome for Energy, Consumer Discretionary, Industrials and Financials," she wrote in a note to clients.
   Treace Medical Concepts, Inc. Secures $50 Million Debt Facility and Expands Revolving Line of Credit  2020/08/04 17:00:00 Business Wire
PONTE VEDRA, Fla.--(BUSINESS WIRE)--Treace Medical Concepts, Inc. (“Treace”), a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announced that it closed on a $50 million non-dilutive term loan agreement with CR Group L.P. (“CRG”), a healthcare focused investment firm. The Company also announced that it now has up to $10 million available under its revolving line of credit with Silicon Valley Bank (“SVB”). Under the term loan with CRG, Treace
   Five Mid-Cap Stocks That Are Positioned For Success  2020/08/03 17:05:44 Benzinga
Mid-caps are generally defined as companies whose market cap does not exceed $10 billion. They can be found in any industry and although some are already highly recognizable, many mid-caps are small enough that they still have plenty of growth potential. This is their advantage over some of their large-cap peers. But due to their size and more volatile financials, many have been injured by the ongoing crisis. Yet, many are also poised for a grand fashion return such as SVB Financial Group (NASDAQ: SIVB ), Skechers USA Inc (NYSE: SKX ), and Appian Corp (NASDAQ: APPN ), Sunhydrogen Inc (OTC: HYSR ) and Contact Gold Corp (OTC: CGOL ). Silicon Valley Banking During downturns, bank stocks may not be the best ones to have in your portfolio. Dow Jones U.S. Banks Index measured that the sector is down 35% this year. However, Silicon Valley Bank Financial Group is only down 10% due to its niche: startups. The company did not perform poorly during the crisis as it added 1,500 new clients. By doing so, it achieved a new record.
   Silicon Valley Bank: Lenders ‘Want to Know’ how COVID-19 has Impacted Your Business  2020/07/29 11:01:01 The Fintech Times
Wondering how to fund your business? @SVB_UK explain just what banks want to know when it comes to #funding in the wake of #COVID-19. The post Silicon Valley Bank: Lenders ‘Want to Know’ how COVID-19 has Impacted Your Business appeared first on The Fintech Times .
   SVB Financial Group : Announces Availability Of Quarterly Financial Results | MarketScreener  2020/07/23 20:53:03 MarketScreener
SANTA CLARA, Calif., July 23, 2020 /PRNewswire/ -- SVB Financial Group has released its financial results for the quarter ended June 30, 2020. Please visit SVB's Investor Relations website at… | July 23, 2020
   Aurinia Announces Public Offering of Common Shares  2020/07/22 20:08:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has commenced a registered underwritten public offering of its common shares (the “Offering”). Jefferies and SVB Leerink are acting as joint book-running managers for the Offering. The Company will grant the underwriters an option exercisabl
   SVB Financial Group : Announces Availability Of Quarterly Financial Results | MarketScreener  2020/07/23 20:53:03 MarketScreener
SANTA CLARA, Calif., July 23, 2020 /PRNewswire/ -- SVB Financial Group has released its financial results for the quarter ended June 30, 2020. Please visit SVB's Investor Relations website at… | July 23, 2020
   Aurinia Announces Public Offering of Common Shares  2020/07/22 20:08:00 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has commenced a registered underwritten public offering of its common shares (the “Offering”). Jefferies and SVB Leerink are acting as joint book-running managers for the Offering. The Company will grant the underwriters an option exercisabl
   CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock  2020/07/22 11:22:00 Benzinga Feeds
MONMOUTH JUNCTION, N.J. , July 22, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ) (the "Company"), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, today announced the pricing of its previously announced underwritten public offering of 5,263,158 shares of its common stock at a public offering price of $9.50 per share, resulting in gross proceeds of approximately $50.0 million before deducting underwriting discounts and commissions and other offering expenses. CTSO ) is a leader in blood purification to treat cytokine storm and deadly inflammation in life-threatening illnesses with its flagship product, CytoSorb. CytoSorb is approved in the European Union and distributed in 58 countries worldwide. (PRNewsfoto/CytoSorbents Corporation)" alt="CytoSorbents Corporation (NASDAQ: CTSO ) is a leader in blood purification to treat cytokine storm and deadly inflammation in life-threatening illnesses with its flagship product, CytoSorb.
   The EU agrees a historic, unprecedented $860 billion recovery fund as the bloc fights the fallout of coronavirus  2020/07/21 08:46:57 Business Insider
Leaders of the European Union reached a historic deal Tuesday on an $860 billion recovery fund aimed at the reconstruction of the 27-member bloc. By the end of a 4-day summit, the heads of states agreed on distributing 390 billion euros ($446 billion) in grants, and 360 billion euros ($412 billion) in loans after reaching a compromise with a group of nations nicknamed the "Frugal Four." The EU's seven-year budget, which supports long-term green and digital investments, was ratified at 1.8 trillion euros ($2 trillion). New debt from the recovery package is expected to be repaid by 2058. Visit Business Insider's homepage for more stories . EU leaders have agreed on a landmark 750 billion euro ($860 billion) recovery fund for the reconstruction of the region disrupted by the coronavirus pandemic. The agreement was made public after European council president, Charles Michel, tweeted "Deal!" early Tuesday. "These were, of course, difficult negotiations in very difficult times for all Europeans," he said in a statement.
   Bank of India and Silicon Valley Bank launch Covid-19 business loans | London Business News | Londonlovesbusiness.com  2020/07/20 13:06:56 London Loves Business
The British Business Bank has accredited the Bank of India under the Coronavirus Business Interruption Loan Scheme (CBILS) and Silicon Valley Bank under the Coronavirus Large Business Interruption Loan Scheme (CLBILS). Bank of India will be able to provide financial support to smaller businesses across the UK that are losing revenue and seeing their cashflowRead More

calendar